Nutricircle Limited
- Market cap
- ₹ 294 Cr.
- P/E
- 979x
- P/B
- 42.43x
- 52-week range
- 204.5 – 411.4
- ROE
- 5%
- ROCE
- 4.2%
- Dividend yield
- 0%
- Debt / equity
- 0.16
- Sector
- Food Products
- Industry
- Other Food Products
- Listed on
- BSE
About
Nutricircle Limited is an India-based research and development (R&D) science-based company. The Company is mainly in the business of plant protein and plant nutrition-based products. Its nutraceutical offerings include My45 Nutrients, GoSlender, and Fly High. My45 Nutrients is rich in all the essential nutrients a human body needs. This daily dose of goodness contains eight vitamins, 29 amino acids, bio-nutrients, plant extract and eight minerals. Its GoSlender is an herbal product for weight loss. Fly High capsules are the ultimate supplement capsules. Its products also include bajra (pearl millet), jowar (sorghum), kangni (foxtail), quinoa, and others.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Other Food Products: 42 companies →Nutricircle Limited against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)979 against a typical 19.6: pricier than most peers (1st = cheapest).41st of 41
- Sales growth+151.1% against a typical +23.5% from a year earlier.2nd of 25
- Profit growth+33.3% against a typical +29.7% from a year earlier.10th of 22
- Share price, 3 months−3.3% against a typical −6%.19th of 40
- Size₹ 293.7 Cr. market value against a typical ₹ 118.1 Cr. (1st = largest).11th of 39
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1 | 2 | 0 | 0 | 0 | 1 | 1 | 2 | 5 | 6 | 5 | 6 |
| Expenses | 1 | 2 | 1 | 0 | 0 | 2 | 0 | 2 | 5 | 5 | 5 | 5 |
| Operating Profit | −0 | −0 | −1 | −0 | −0 | −0 | 1 | 0 | 0 | 0 | 0 | 0 |
| OPM % | −11.1% | −13.2% | — | — | — | −7.5% | 62.4% | 1.4% | 1.2% | 3.3% | 0.2% | 0.7% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | −0 | −0 | −1 | −0 | −0 | −0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | −0 | −0 | −1 | −0 | −0 | −0 | 1 | 0 | 0 | 0 | 0 | 0 |
| EPS in Rs | −2.94 | −10.3 | −19.13 | −13.61 | −6.25 | −0.11 | 0.78 | 0.03 | 0.06 | 0.18 | 0.02 | 0.04 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 54%
- 5 Years
- —
- 3 Years
- 109%
- TTM
- 330%
- 10 Years
- 9%
- 5 Years
- 23%
- 3 Years
- 42%
- TTM
- −43%
- 10 Years
- 42%
- 5 Years
- 26%
- 3 Years
- 5%
- TTM
- —
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Nutricircle Limited | ₹ 264.60 | ₹ 294 Cr. | 979x | 42.4x | 5% | — |
| Sun Pharmaceutical Industries | ₹ 1,748.00 | ₹ 4,19,394 Cr. | 38.2x | 5.5x | — | 19.8% |
| Divi's Laboratories | ₹ 8,950.00 | ₹ 2,37,594 Cr. | 89.5x | 14x | — | 26.1% |
| Torrent Pharmaceuticals | ₹ 4,660.00 | ₹ 1,77,245 Cr. | 76.5x | 20.2x | — | 13.7% |
| Zydus Lifesciences | ₹ 1,129.40 | ₹ 1,12,658 Cr. | 21.7x | 4.3x | — | 15.7% |
| Cipla | ₹ 1,338.00 | ₹ 1,08,091 Cr. | 28.2x | 3.4x | — | 11.9% |
Management
- Sunil Kumar Agarwal
- Chief Financial Officer
- Aakansha Vaid
- Compliance Officer, Company Secretary
- Hitesh Mohanlal Patel
- Managing Director, Executive Director
- Chandra Sheker Jadhav
- Whole Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.